Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,870.00 ILa | +1.78% |
|
+13.47% | +7.73% |
| 07-30 | Teva CEO on Drug Pipeline, Direct Listing on NYSE | MT |
| 07-29 | Teva Pharmaceutical Industries Limited Reports Unaudited Consolidated Impairment Charges for the Second Quarter Ended June 30, 2026 | CI |
| Market Cap | 40.8B 0 35.46B 33.01B 30.31B 57.23B 3,895B 58.12B 389B 153B 1,939B 153B 150B 6,501B | P/E 2026 * |
47x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 52.67B 0 45.79B 42.62B 39.13B 73.9B 5,028B 75.04B 502B 197B 2,503B 198B 193B 8,394B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.86x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +1.78% | ||
| 1 week | +13.47% | ||
| 1 month | +10.50% | ||
| 3 months | +4.72% | ||
| 6 months | +7.62% | ||
| Current year | +7.73% |
| 1 week | 9,450 |  | 10,970 |
| 1 month | 9,396 | | 10,970 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 3,002 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 20,860 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.78% | +13.47% | - | - | 40.8B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -1.06% | -1.20% | +30.11% | +49.75% | 397.08B | |
| Weighted average by Cap. | -0.96% | -1.93% | +39.24% | +72.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.58B 0 14.41B 13.42B 12.32B 23.26B 1,583B 23.62B 158B 62.07B 788B 62.28B 60.91B 2,642B | 17.3B 0 15.04B 14B 12.86B 24.28B 1,652B 24.65B 165B 64.77B 822B 64.99B 63.56B 2,758B |
| Net income | 1.14B 0 991M 923M 847M 1.6B 109B 1.62B 10.88B 4.27B 54.2B 4.28B 4.19B 182B | 2.34B 0 2.03B 1.89B 1.74B 3.28B 223B 3.33B 22.29B 8.75B 111B 8.78B 8.58B 372B |
| Net Debt | 11.88B 0 10.33B 9.61B 8.82B 16.66B 1,134B 16.92B 113B 44.46B 564B 44.61B 43.63B 1,893B | 8.61B 0 7.49B 6.97B 6.4B 12.08B 822B 12.27B 82.13B 32.23B 409B 32.34B 31.63B 1,372B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ILA 10,870.00 | +1.78% | 672,031 |
| 30/07/26 | ILA 10,680.00 | +1.14% | 1,803,433 |
| 29/07/26 | ILA 10,560.00 | +10.17% | 2,354,552 |
| 28/07/26 | ILA 9,585.00 | +0.89% | 831,774 |
| 27/07/26 | ILA 9,500.00 | -0.84% | 1,193,392 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
